Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387207949> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4387207949 endingPage "e11" @default.
- W4387207949 startingPage "e11" @default.
- W4387207949 abstract "In recent years, many studies have shown that lipids and lipid-like substances are key regulatory factors in tumor development and play an important role in immune regulation. However, it remains unclear whether serum lipids influence the outcome of immunotherapy. Therefore, determining the serum lipid levels of the immune treatment-beneficiary population may be valuable. The aim of this study is to evaluate the prognostic value of baseline serum lipid levels in non-small cell lung cancer (NSCLC) patients receiving immunotherapy.We retrospectively included 294 patients with stage III-IV NSCLC who received immunotherapy continuously from December 2018 to November 2021 at our hospital, collecting their pre-treatment lipid levels, such as total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C). Of these, 160 receiving immunotherapy without combined radiotherapy (ICIs-nRT) and 134 combined with radiotherapy (iRT). The endpoint was the correlation between pre-treatment serum lipid levels and overall survival (OS), as well as progression-free survival (PFS). The X-tile tool was used to determine the optimal cut-off value of the indicators. The Kaplan-Meier survival curves were used to calculate OS and PFS and log rank tests were used for comparison. And the Cox proportional hazard model were used for univariate and multivariate analysis.In all 294 patients, low TG, low TC, and low HDL-C predicted poor OS (P<0.001) and poor PFS (P<0.05). Low LDL-C was associated with poor OS (P = 0.0001). Among 160 patients receiving ICIs-nRT and 134 iRT patients, low levels of TG (P = 0.0134, 0.0024), TC (P = 0.0003, 0.0023), HDL-C (P = 0.0004, 0.0043), and LDL-C (P = 0.0003, 0.0419) were associated with worse OS compared to high levels of them. In the ICIs-nRT patients, low HDL-C predicted poor PFS (P = 0.0011). In 134 iRT patients, low levels of TG (P = 0.0017), TC (P = 0.0028), and LDL-C (P = 0.0330) were poor prognostic factors for PFS. In the univariate and multivariate analysis with OS in all patients, TG and HDL-C were independent risk factors, while TG was an independent risk factor in the analysis with PFS. In ICIs-nRT patients, HDL-C was an independent prognostic factor for patients' OS and PFS. In iRT patients, both TG and HDL-C were prognostic risk factors for OS.These data confirm that higher serum lipid levels are associated with better outcomes in patients with NSCLC undergoing immunotherapy. Serum lipids may identify tumors that are more likely to respond to immunotherapy. Radiation therapy may affect lipid metabolism within the body to enhance the efficacy of immunotherapy." @default.
- W4387207949 created "2023-09-30" @default.
- W4387207949 creator A5005958296 @default.
- W4387207949 creator A5019448133 @default.
- W4387207949 creator A5022151811 @default.
- W4387207949 creator A5026906414 @default.
- W4387207949 creator A5034746982 @default.
- W4387207949 creator A5066541463 @default.
- W4387207949 creator A5067172872 @default.
- W4387207949 creator A5067904554 @default.
- W4387207949 creator A5083552183 @default.
- W4387207949 creator A5086529957 @default.
- W4387207949 date "2023-10-01" @default.
- W4387207949 modified "2023-10-17" @default.
- W4387207949 title "The Baseline Serum Lipid Levels and Outcomes of NSCLC Patients Receiving Immunotherapy Combined or Non-Combined with Radiotherapy: A Single Center Retrospective Study" @default.
- W4387207949 doi "https://doi.org/10.1016/j.ijrobp.2023.06.670" @default.
- W4387207949 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37784645" @default.
- W4387207949 hasPublicationYear "2023" @default.
- W4387207949 type Work @default.
- W4387207949 citedByCount "0" @default.
- W4387207949 crossrefType "journal-article" @default.
- W4387207949 hasAuthorship W4387207949A5005958296 @default.
- W4387207949 hasAuthorship W4387207949A5019448133 @default.
- W4387207949 hasAuthorship W4387207949A5022151811 @default.
- W4387207949 hasAuthorship W4387207949A5026906414 @default.
- W4387207949 hasAuthorship W4387207949A5034746982 @default.
- W4387207949 hasAuthorship W4387207949A5066541463 @default.
- W4387207949 hasAuthorship W4387207949A5067172872 @default.
- W4387207949 hasAuthorship W4387207949A5067904554 @default.
- W4387207949 hasAuthorship W4387207949A5083552183 @default.
- W4387207949 hasAuthorship W4387207949A5086529957 @default.
- W4387207949 hasConcept C10515644 @default.
- W4387207949 hasConcept C121608353 @default.
- W4387207949 hasConcept C126322002 @default.
- W4387207949 hasConcept C143998085 @default.
- W4387207949 hasConcept C168563851 @default.
- W4387207949 hasConcept C203092338 @default.
- W4387207949 hasConcept C207103383 @default.
- W4387207949 hasConcept C2776256026 @default.
- W4387207949 hasConcept C2777701055 @default.
- W4387207949 hasConcept C38180746 @default.
- W4387207949 hasConcept C44249647 @default.
- W4387207949 hasConcept C50382708 @default.
- W4387207949 hasConcept C509974204 @default.
- W4387207949 hasConcept C71924100 @default.
- W4387207949 hasConceptScore W4387207949C10515644 @default.
- W4387207949 hasConceptScore W4387207949C121608353 @default.
- W4387207949 hasConceptScore W4387207949C126322002 @default.
- W4387207949 hasConceptScore W4387207949C143998085 @default.
- W4387207949 hasConceptScore W4387207949C168563851 @default.
- W4387207949 hasConceptScore W4387207949C203092338 @default.
- W4387207949 hasConceptScore W4387207949C207103383 @default.
- W4387207949 hasConceptScore W4387207949C2776256026 @default.
- W4387207949 hasConceptScore W4387207949C2777701055 @default.
- W4387207949 hasConceptScore W4387207949C38180746 @default.
- W4387207949 hasConceptScore W4387207949C44249647 @default.
- W4387207949 hasConceptScore W4387207949C50382708 @default.
- W4387207949 hasConceptScore W4387207949C509974204 @default.
- W4387207949 hasConceptScore W4387207949C71924100 @default.
- W4387207949 hasIssue "2" @default.
- W4387207949 hasLocation W43872079491 @default.
- W4387207949 hasLocation W43872079492 @default.
- W4387207949 hasOpenAccess W4387207949 @default.
- W4387207949 hasPrimaryLocation W43872079491 @default.
- W4387207949 hasRelatedWork W2118215538 @default.
- W4387207949 hasRelatedWork W2340130805 @default.
- W4387207949 hasRelatedWork W2361700749 @default.
- W4387207949 hasRelatedWork W2407189953 @default.
- W4387207949 hasRelatedWork W2607758844 @default.
- W4387207949 hasRelatedWork W2994686985 @default.
- W4387207949 hasRelatedWork W3004966710 @default.
- W4387207949 hasRelatedWork W3048057313 @default.
- W4387207949 hasRelatedWork W4220655021 @default.
- W4387207949 hasRelatedWork W4283162095 @default.
- W4387207949 hasVolume "117" @default.
- W4387207949 isParatext "false" @default.
- W4387207949 isRetracted "false" @default.
- W4387207949 workType "article" @default.